316 related articles for article (PubMed ID: 24584970)
1. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Ganor Y; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
[TBL] [Abstract][Full Text] [Related]
2. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
4. Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
Ganor Y; Grinberg I; Reis A; Cooper I; Goldstein RS; Levite M
Leuk Lymphoma; 2009 Jun; 50(6):985-97. PubMed ID: 19391040
[TBL] [Abstract][Full Text] [Related]
5. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.
Ganor Y; Besser M; Ben-Zakay N; Unger T; Levite M
J Immunol; 2003 Apr; 170(8):4362-72. PubMed ID: 12682273
[TBL] [Abstract][Full Text] [Related]
6. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage.
Ganor Y; Teichberg VI; Levite M
J Immunol; 2007 Jan; 178(2):683-92. PubMed ID: 17202328
[TBL] [Abstract][Full Text] [Related]
7. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
8. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
10. Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.
Saussez S; Laumbacher B; Chantrain G; Rodriguez A; Gu S; Wank R; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1007-27. PubMed ID: 25030361
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases.
Levite M
Acta Physiol (Oxf); 2016 Jan; 216(1):42-89. PubMed ID: 25728499
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells.
Levite M; Safadi R; Milgrom Y; Massarwa M; Galun E
Neuropeptides; 2021 Oct; 89():102159. PubMed ID: 34293596
[TBL] [Abstract][Full Text] [Related]
13. Glutamate and its receptors in cancer.
Stepulak A; Rola R; Polberg K; Ikonomidou C
J Neural Transm (Vienna); 2014 Aug; 121(8):933-44. PubMed ID: 24610491
[TBL] [Abstract][Full Text] [Related]
14. Dopamine, T cells and multiple sclerosis (MS).
Levite M; Marino F; Cosentino M
J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756
[TBL] [Abstract][Full Text] [Related]
15. Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation.
Pacheco R; Ciruela F; Casadó V; Mallol J; Gallart T; Lluis C; Franco R
J Biol Chem; 2004 Aug; 279(32):33352-8. PubMed ID: 15184389
[TBL] [Abstract][Full Text] [Related]
16. New role of glutamate as an immunoregulator via glutamate receptors and transporters.
Xue H; Field CJ
Front Biosci (Schol Ed); 2011 Jun; 3(3):1007-20. PubMed ID: 21622250
[TBL] [Abstract][Full Text] [Related]
17. Development of glutamate receptors in auditory neurons from long-term organotypic cultures of the embryonic chick hindbrain.
Diaz C; Martinez-Galan JR; Juiz JM
Eur J Neurosci; 2009 Jan; 29(2):213-30. PubMed ID: 19200228
[TBL] [Abstract][Full Text] [Related]
18. Dendritic and somatic glutamate receptor channels in rat cerebellar Purkinje cells.
Häusser M; Roth A
J Physiol; 1997 May; 501 ( Pt 1)(Pt 1):77-95. PubMed ID: 9174996
[TBL] [Abstract][Full Text] [Related]
19. Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents.
Zamalloa T; Bailey CP; Pineda J
Br J Pharmacol; 2009 Feb; 156(4):649-61. PubMed ID: 19226256
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin-induced glutamate release is implicated in nociceptive processing through activation of ionotropic glutamate receptors and group I metabotropic glutamate receptor in primary afferent fibers.
Jin YH; Yamaki F; Takemura M; Koike Y; Furuyama A; Yonehara N
J Pharmacol Sci; 2009 Feb; 109(2):233-41. PubMed ID: 19202316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
